78418-02-7

Basic information

• Product Name: 5-n-decanoylsalicylic acid
• Synonyms: 5-n-decanoylsalicylic acid
• CAS NO: 78418-02-7
• Molecular Weight: 292.375
• Mol File: 78418-02-7.mol

Chemical Properties

• CAS DataBase Reference: 5-n-decanoylsalicylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-n-decanoylsalicylic acid(78418-02-7)
• EPA Substance Registry System: 5-n-decanoylsalicylic acid(78418-02-7)

Safety Data

• Hazardous Substances Data: 78418-02-7(Hazardous Substances Data)

Upstream product

• 112-13-0 n-decanoyl chloride 
• 69-72-7 salicylic acid 
• 78417-97-7 methyl 5-(n-decanoyl)salicylate 
• 119-36-8 methyl salicylate 
• 107094-29-1 methyl 2-(n-decanoyloxy)benzoate 

Downstream Products

• 28488-51-9 5-decyl-2-hydroxybenzoic acid 
• 97431-10-2 5-Decyl-2-(1,4,7,10-tetraoxa-cyclotridec-5-ylmethoxy)-benzoic acid 
• 107094-30-4 5-Decyl-2-(1,4,7,10-tetraoxa-cyclotridec-5-ylmethoxy)-benzoic acid methyl ester 
• 107106-30-9 5-Decyl-2-(1,4,8,11-tetraoxa-cyclotetradec-6-ylmethoxy)-benzoic acid methyl ester 
• 97431-13-5 5-Decyl-2-(1,4,8,11-tetraoxa-cyclotetradec-6-ylmethoxy)-benzoic acid 
• 107106-32-1 5-Decyl-2-(1,4,7,10,13-pentaoxa-cyclohexadec-15-ylmethoxy)-benzoic acid methyl ester 
• 107094-14-4 5-Decyl-2-(1,4,7,10,13-pentaoxa-cyclohexadec-15-ylmethoxy)-benzoic acid 
• 107094-15-5 5-Decyl-2-(1,4,7,10,13,16-hexaoxa-cyclononadec-8-ylmethoxy)-benzoic acid 
• 107106-33-2 5-Decyl-2-(1,4,7,10,13,16-hexaoxa-cyclononadec-8-ylmethoxy)-benzoic acid methyl ester 
• 107123-14-8 5-Decyl-2-(1,4,7,10,13,16,19,22-octaoxa-cyclotetracos-2-ylmethoxy)-benzoic acid methyl ester 
• 107094-16-6 5-Decyl-2-(1,4,7,10,13,16,19,22-octaoxa-cyclotetracos-2-ylmethoxy)-benzoic acid 
• 107094-17-7 5-Decyl-2-(1,4,7,10,13,16,19,22,25-nonaoxa-cycloheptacos-2-ylmethoxy)-benzoic acid 
• 107106-34-3 5-Decyl-2-(1,4,7,10,13,16,19,22,25-nonaoxa-cycloheptacos-2-ylmethoxy)-benzoic acid methyl ester 
• 107106-35-4 2-(1,4,7,10,13,16,19,22,25,28-Decaoxa-cyclotriacont-2-ylmethoxy)-5-decyl-benzoic acid methyl ester 

Relevant articles and documents

Synthesis and biological evaluation of the salicylamide and salicylic acid derivatives as anti-estrogen agents

Alkylphenols have xenoestrogenic activity, which mimic the action of physiological estrogens and these mimicking activities are mainly mediated by nongenomic pathway. Nongenomic pathway plays a pivotal role in breast, endometrial and ovarian cancers' growth and development. In this study, various alkylphenol derivatives were prepared and screened for their anti-uterotrophic and uterotrophic activity. Among these compounds, 2-hydroxy-5-nonanoylbenzamide (compound 1b) showed 93.99% inhibitory activity in the anti-uterotrophic test performed, and was found inactive in the uterotrophic activity test. Moreover, all test compounds were examined for the effect on uterine histopathological changes, and plasma 17β-estradiol (E2) level. Compound 1b was also tested for in vitro anti-cancer activity against ER+, human breast cancer cell line MCF-7, and it reduced cell viability to 74.01% at 50 nM concentration.

Synthesis of Lipophilic Crown Ethers with Pendant Carboxylic Acid Groups

Synthetic routes to thirteen highly lipophilic crown ether carboxylic acids are described.Seven contain 12-15-membered crown ether units with four ring oxygens and are designed for lithium ion complexation.Three others possess large ring 24-crown-8,27-cro

Novel salicylanilides and microbiocidal compositions and uses thereof

The composition comprises certain 5-acylsalicylanilides and more particularly comprises the compounds encompassed by the following generic formula: STR1 Where Z is a substituted phenyl ring of from 6 to 30 carbon atoms including substituents, R is a subst